EAM
RMD icon

Empirical Asset Management’s ResMed RMD Stock Holding History

Empirical Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500K Sell
2,566
-40
-2% -$8.29K 0.11% 237
2026
Q1 		$585K Sell
2,606
-105
-4% -$26.2K 0.15% 187
2025
Q4 		$653K Sell
2,711
-355
-12% -$90.8K 0.18% 159
2025
Q3 		$839K Buy
+3,066
New +$837K 0.23% 130
2024
Q2 		– Sell
-1,528
Closed -$302K – 382
2024
Q1 		$302K Buy
1,528
+318
+26% +$58.3K 0.15% 204
2023
Q4 		$208K Buy
+1,210
New +$186K 0.17% 170

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Empirical Asset Management's RMD Position: Q2 2026 in Review

Empirical Asset Management reduced its ResMed (RMD) stake by 1.5% in Q2 2026, selling an estimated $8.29K and leaving 2,566 shares worth $500K. The position accounts for 0.11% of the portfolio, ranked #237.

Empirical Asset Management first reported a position in RMD in Q4 2023 and has held it in 6 quarters since. The position peaked at $839K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Empirical Asset Management held 2,566 shares of ResMed worth $500K as of Q2 2026.
  • Empirical Asset Management sold 40 ResMed shares in Q2 2026, an estimated $8.29K.
  • ResMed made up 0.11% of Empirical Asset Management's portfolio in Q2 2026, its #237 holding.
  • Empirical Asset Management first reported a position in ResMed in Q4 2023 and has held it in 6 quarters since.
  • Empirical Asset Management's ResMed position peaked at $839K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.